SDZ-220-581

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

SDZ-220-581

Specification
Cat. No.
SMD1771
Related Diseases
Schizophrenia
Product Name
SDZ-220-581
Size
Customizable
Price
Inquiry
Description
SDZ-220-581 is a potent, competitive antagonist at the NMDA glutamate receptor subtype, reversed haloperidol-induced catalepsy in rats, a widely used model of Parkinson's disease.
CAS Number
174575-17-8 (free)
Chemical Formula
C16H17ClNO5P
Exact Mass
369.0533
Molecular Weight
369.7378
Elemental Analysis
C, 51.98; H, 4.63; Cl, 9.59; N, 3.79; O, 21.64; P, 8.38
Synonym
SDZ-220-581; SDZ 220-581; SDZ220-581. SDZ-220581; SDZ 220581; SDZ220581.
IUPAC/Chemical Name
(S)-2-amino-3-(2'-chloro-5-(phosphonomethyl)-[1,1'-biphenyl]-3-yl)propanoic acid
SMILES Code
O=C(O)[C@@H](N)CC1=CC(C2=CC=CC=C2Cl)=CC(CP(O)(O)=O)=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top